دورية أكاديمية
Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment.
| العنوان: | Patient' and social aspects related to complementary mistletoe therapy in patients with breast cancer: A systematic review commissioned by the German agency for Health Technology Assessment. |
|---|---|
| المؤلفون: | Steigenberger C; Institute for Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, 6060, Hall in Tirol, Austria. Electronic address: caroline.steigenberger@umit-tirol.at., Schnell-Inderst P; Institute for Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, 6060, Hall in Tirol, Austria., Flatscher-Thöni M; Institute for Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, 6060, Hall in Tirol, Austria., Plank LM; Institute for Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, 6060, Hall in Tirol, Austria., Siebert U; Institute for Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health, Health Services Research and Health Technology Assessment, UMIT TIROL - University for Health Sciences and Technology, Eduard-Wallnoefer-Zentrum 1, 6060, Hall in Tirol, Austria; Institute for Technology Assessment and Department of Radiology, Massachusetts General Hospital, Harvard Medical School, 101 Merrimac Street, Boston, MA, 02114, USA; Center for Health Decision Science, Departments of Epidemiology and Health Policy & Management, Harvard T.H. Chan School of Public Health, 677 Huntington Avenue, Boston, MA, 02115, USA; Division of Health Technology Assessment, ONCOTYROL - Center for Personalized Cancer Medicine, Karl-Kapferer-Str. 5, 6020, Innsbruck, Austria. |
| المصدر: | European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2023 Aug; Vol. 65, pp. 102338. Date of Electronic Publication: 2023 May 07. |
| نوع المنشور: | Systematic Review; Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100885136 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2122 (Electronic) Linking ISSN: 14623889 NLM ISO Abbreviation: Eur J Oncol Nurs Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Edinburgh ; New York : Churchill Livingstone, c1998- |
| مواضيع طبية MeSH: | Mistletoe* , Antineoplastic Agents, Phytogenic*/adverse effects , Breast Neoplasms*/drug therapy , Viscum album*, Humans ; Female ; Plant Extracts/therapeutic use ; Phytotherapy/adverse effects ; Phytotherapy/methods ; Quality of Life ; Technology Assessment, Biomedical |
| مستخلص: | Purpose: To mitigate side effects of conventional cancer care and improve quality of life, many patients with breast cancer in German-speaking countries opt for mistletoe therapy in addition to standard treatment. To understand the value for users, we evaluated the domain "Patient and Social aspects" in a health technology assessment on complementary mistletoe therapy in patients with breast cancer. Methods: A systematic review was conducted according to PRISMA guidelines. Fifteen electronic databases and the internet were searched. Qualitative studies were analyzed using qualitative content analysis; quantitative studies were systematically summarized in evidence tables. Results: Seventeen studies out of 1203 screened publications with 4765 patients and 869 healthcare professionals were included in the review. The median proportion of patients using mistletoe therapy was 26.7% (range: 7.3-46.3%). Predictors for use were younger age and higher educational level. Main reasons for patients' use of mistletoe therapy were to leave nothing untried and to be actively involved in the treatment process. Reasons against use were related to a lack of knowledge or uncertainty regarding effectiveness and safety. Physicians mainly aimed to support the patient's physical condition as main reason for use and a lack of resources and knowledge as main reason against use. Conclusion: Mistletoe therapy was commonly used in the treatment of breast cancer despite a lack of scientific knowledge among patients and physicians. Transparent communication on motivation for use and its potential effect enables realistic expectations. Relatively small samples of mistletoe therapy users limit the representativeness and validity of our results. Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. (Copyright © 2023 Elsevier Ltd. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Breast neoplasms; Germany; Health technology assessment; Integrative medicine; Mistletoe; Patients; Systematic review; Viscum album |
| المشرفين على المادة: | 0 (Plant Extracts) 0 (Antineoplastic Agents, Phytogenic) |
| تواريخ الأحداث: | Date Created: 20230615 Date Completed: 20230724 Latest Revision: 20230724 |
| رمز التحديث: | 20240513 |
| DOI: | 10.1016/j.ejon.2023.102338 |
| PMID: | 37321128 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1532-2122 |
|---|---|
| DOI: | 10.1016/j.ejon.2023.102338 |